Table 1 Demographics characteristics between AAE (+) and AAE (-).
AAE (+) (N = 56) | AAE (-) (N = 95) | P value | |
|---|---|---|---|
Demographics | |||
Age, mean (SD), year | 61.54 (8.38) | 61.34 (8.73) | 0.891 |
Male, No. (%) | 41 (73.21%) | 65 (68.42%) | 0.584 |
Risk factors | |||
HTN, No. (%) | 54 (96.43%) | 83 (87.37%) | 0.083 |
DM, No. (%) | 32 (57.14%) | 60 (63.16%) | 0.493 |
HLD, No. (%) | 22 (39.29%) | 43 (45.26%) | 0.501 |
CHD, No. (%) | 22 (39.29%) | 27 (28.42%) | 0.208 |
Smoking, No. (%) | 20 (35.71%) | 32 (33.68%) | 0.86 |
Medications before stroke | |||
Statin, No. (%) | 15 (26.79%) | 16 (16.84%) | 0.151 |
Antiplatelet agents, No. (%) | 15 (26.79%) | 20 (21.05%) | 0.431 |
Laboratory data | |||
HDL, median (IQR), mg/dL | 19.62 (17.15, 22.82) | 19.08 (15.84, 21.60) | 0.517 |
LDL, median (IQR), mg/dL | 37.08 (29.88, 55.03) | 40.14 (31.32, 51.12) | 0.884 |
TC, median (IQR), mg/dL | 63.54 (54.54, 84.11) | 67.32 (57.24, 80.10) | 0.967 |
TG, median (IQR), mg/dL | 23.49 (19.89, 32.58) | 24.30 (18.00, 31.50) | 0.581 |
Time interval from symptoms onset to MRI study, median (IQR), day | 20 (14, 28) | 17.5 (8, 28) | 0.232 |
Infarct locations | 81 | 150 | 0.947 |
Medulla | 4 (4.94%) | 5 (3.33) | |
Pons | 32 (39.51%) | 54 (36%) | |
Midbrain | 0 | 1 (0.67%) | |
Cerebellum | 25 (30.86%) | 47 (31.34%) | |
Occipital lobe | 15 (18.52%) | 28 (18.67%) | |
Temporal lobe | 1 (1.23%) | 5 (3.33%) | |
Thalamus | 2 (2.47%) | 5 (3.33%) | |
Callosum | 2 (2.47%) | 5 (3.33%) | |
